שווי פירמה כולל: Glaukos Corporation (GKOS)

Glaukos Corporation (GKOS) generates revenue by implementing ophthalmological microsystems into surgery, building a loyal pool of physicians and securing high margins from consumables. This chart confirms the business valuation, which stands at 10518.07. Revenue stability is underpinned by the critical nature of these procedures, which remain independent of economic crises. The company is currently scaling sales of innovative devices and expanding insurance coverage.

This metric determines the investment attractiveness of Glaukos Corporation (GKOS) by summing market capitalization with net debt to calculate the total enterprise value for a business buyout. By analyzing the net market price of the business, the investor assesses the actual scale of assets, the stability of which is bolstered by efficient air delivery of micro-implants, eliminating the logistical risks and delays typical of traditional ocean freight.